Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Balance Sheets

v3.5.0.2
Interim Consolidated Balance Sheets - USD ($)
Aug. 31, 2016
Nov. 30, 2015
CURRENT    
Cash and cash equivalent $ 488,224 $ 1,851,021
Accounts Receivable 14,874 39,676
Inventory 16,984 44,319
Deferred financing costs 59,216 63,741
Prepaid expenses and other receivables 83,623 27,283
Total Current Assets 662,921 2,026,040
Deferred financing costs 0 43,367
Property and Equipment 62,124 97,011
TOTAL ASSETS 725,045 2,166,418
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 82,468 173,329
Convertible Debentures 1,398,592 0
Total Current Liabilities 1,481,060 173,329
Convertible Debentures 0 1,398,592
Total Liabilities 1,481,060 1,571,921
Capital Stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2015 - nil). 0 0
Common stock, $0.001 par value 100,000,000 shares authorized (2015: 100,000,000), 54,615,642 issued and outstanding (2015: 54,615,642) 54,616 54,616
Additional Paid-In Capital 27,182,401 27,179,827
Deficiency (27,937,161) (26,593,207)
Accumulated other comprehensive loss (55,871) (46,739)
Total Stockholders' Equity (Deficiency) (756,015) 594,497
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) $ 725,045 $ 2,166,418